Sachem Capital Corp. Equity Method Investments decreased by 10.0% to $35.24M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 34.7%, from $53.94M to $35.24M.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.84M | $1.80M | $6.06M | $17.41M | $19.62M | $22.54M | $30.83M | $35.32M | $35.40M | $39.96M | $43.04M | $46.22M | $46.95M | $54.12M | $53.94M | $53.94M | $48.71M | $41.17M | $39.13M | $35.24M |
| QoQ Change | — | -2.1% | +235.6% | +187.6% | +12.7% | +14.9% | +36.8% | +14.6% | +0.2% | +12.9% | +7.7% | +7.4% | +1.6% | +15.3% | -0.3% | -0.0% | -9.7% | -15.5% | -4.9% | -10.0% |
| YoY Change | — | — | — | — | +964.2% | >999% | +409.1% | +102.8% | +80.5% | +77.3% | +39.6% | +30.9% | +32.6% | +35.4% | +25.3% | +16.7% | +3.7% | -23.9% | -27.5% | -34.7% |